- Home
- SES vs ANGO Comparison
SES vs ANGO Comparison
Compare SES & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SES
- ANGO
- Stock Information
- Founded
- SES 2012
- ANGO 1988
- Country
- SES United States
- ANGO United States
- Employees
- SES N/A
- ANGO N/A
- Industry
- SES Auto Parts:O.E.M.
- ANGO Medical/Dental Instruments
- Sector
- SES Consumer Discretionary
- ANGO Health Care
- Exchange
- SES Nasdaq
- ANGO Nasdaq
- Market Cap
- SES 340.3M
- ANGO 400.8M
- IPO Year
- SES N/A
- ANGO 2004
- Fundamental
- Price
- SES $1.09
- ANGO $8.77
- Analyst Decision
- SES Hold
- ANGO Strong Buy
- Analyst Count
- SES 3
- ANGO 3
- Target Price
- SES $1.50
- ANGO $19.00
- AVG Volume (30 Days)
- SES 8.6M
- ANGO 476.3K
- Earning Date
- SES 08-04-2025
- ANGO 10-02-2025
- Dividend Yield
- SES N/A
- ANGO N/A
- EPS Growth
- SES N/A
- ANGO N/A
- EPS
- SES N/A
- ANGO N/A
- Revenue
- SES $11,360,000.00
- ANGO $292,498,000.00
- Revenue This Year
- SES $916.42
- ANGO $7.13
- Revenue Next Year
- SES $151.67
- ANGO $6.28
- P/E Ratio
- SES N/A
- ANGO N/A
- Revenue Growth
- SES N/A
- ANGO N/A
- 52 Week Low
- SES $0.20
- ANGO $5.83
- 52 Week High
- SES $2.53
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- SES 49.36
- ANGO 46.00
- Support Level
- SES $0.99
- ANGO $8.68
- Resistance Level
- SES $1.21
- ANGO $9.18
- Average True Range (ATR)
- SES 0.10
- ANGO 0.32
- MACD
- SES -0.03
- ANGO 0.05
- Stochastic Oscillator
- SES 25.32
- ANGO 42.71
About SES SES AI Corporation
SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.